LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 521

Search options

  1. Book: Bridging

    Spannagl, Michael / Spannagel, Uwe

    perioperative Umstellung von oraler Antikoagulation auf niedermolekulare Heparine ; 13 Tabellen

    (Auf einen Blick)

    2011  

    Author's details Michael Spannagl und Uwe Spannagel
    Series title Auf einen Blick
    Keywords Vitamin-K-Antagonist ; Perioperative Phase ; Niedermolekulares Heparin
    Subject Fraktioniertes Heparin ; Low-molecular-weight-Heparin
    Subject code 615.718
    Language German
    Size 52 S. : graph. Darst.
    Edition 2., aktualisierte und erw. Aufl.
    Publisher Ligatur
    Publishing place Stuttgart
    Publishing country Germany
    Document type Book
    Note Literaturangaben
    HBZ-ID HT016891366
    ISBN 978-3-940407-33-7 ; 3-940407-33-X
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  2. Book: Bridging

    Spannagl, Michael / Spannagel, Uwe

    perioperative Umstellung von oraler Antikoagulation auf niedermolekulare Heparine ; 19 Tabellen

    (Auf einen Blick)

    2009  

    Author's details Michael Spannagl ; Uwe Spannagel
    Series title Auf einen Blick
    Keywords Vitamin-K-Antagonist ; Perioperative Phase ; Niedermolekulares Heparin
    Subject Fraktioniertes Heparin ; Low-molecular-weight-Heparin
    Subject code 615.718
    Language German
    Size 45 S. : graph. Darst., 24 cm
    Publisher Ligatur
    Publishing place Stuttgart
    Publishing country Germany
    Document type Book
    Note Literaturverz. S. 39 - 41
    HBZ-ID HT015998020
    ISBN 978-3-940407-11-5 ; 3-940407-11-9
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  3. Article ; Online: Antikoagulation bei Patienten mit COVID-19.

    Pekrul, I / Spannagl, M / Nitschmann, S

    Der Internist

    2021  Volume 62, Issue 11, Page(s) 1253–1255

    Title translation Anticoagulation in patients with COVID-19.
    MeSH term(s) Anticoagulants/adverse effects ; Blood Coagulation ; COVID-19 ; Humans ; SARS-CoV-2
    Chemical Substances Anticoagulants
    Language German
    Publishing date 2021-10-12
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 2913-0
    ISSN 1432-1289 ; 0020-9554
    ISSN (online) 1432-1289
    ISSN 0020-9554
    DOI 10.1007/s00108-021-01190-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Comparison of fecal calprotectin and pancreatic elastase assays based on proficiency testing results.

    Johnson, Lisa M / Spannagl, Michael / Wojtalewicz, Nathalie / Durner, Jürgen

    Clinical biochemistry

    2022  Volume 107, Page(s) 19–23

    Abstract: Background: Fecal calprotectin and fecal pancreatic elastase assays are not standardized because of a lack of suitable reference material. Laboratories may have difficulty in switching assays because different manufacturers do not compare well with each ...

    Abstract Background: Fecal calprotectin and fecal pancreatic elastase assays are not standardized because of a lack of suitable reference material. Laboratories may have difficulty in switching assays because different manufacturers do not compare well with each other despite having similar reference intervals. Data from proficiency testing performed in Germany (Fecal Diagnostics 01 Survey, INSTAND eV) were investigated to understand how results differed across eight calprotectin and five pancreatic elastase manufacturers.
    Methods: Data were collected from participating laboratories in external quality assessment schemes from 2015 to 2020 for calprotectin and 2017 to 2020 for pancreatic elastase. The manufacturer group mean values and standard deviations were calculated. Reference points were created for each external quality assessment scheme by calculating the average of all manufacturer group means. Deming regression analyses were used to observe the differences across manufacturers.
    Results: The slopes of the Deming regression spanned 0.37-1.91 for calprotectin and 0.84-1.33 for pancreatic elastase. The calprotectin assays had a high degree of variability in quantitative results by manufacturer. However, pancreatic elastase assays appear to be harmonized across the different manufacturer when considering the qualitative interpretation.
    Conclusions: Both calprotectin and pancreatic elastase assays could be improved by standardization efforts. Given the clinical utility and our data demonstrating high inter-manufacturer variability, calprotectin should be prioritized over pancreatic elastase in standardization efforts.
    MeSH term(s) Biological Assay ; Clinical Enzyme Tests ; Feces ; Humans ; Leukocyte L1 Antigen Complex ; Pancreatic Elastase
    Chemical Substances Leukocyte L1 Antigen Complex ; Pancreatic Elastase (EC 3.4.21.36)
    Language English
    Publishing date 2022-05-14
    Publishing country United States
    Document type Journal Article
    ZDB-ID 390372-2
    ISSN 1873-2933 ; 0009-9120
    ISSN (online) 1873-2933
    ISSN 0009-9120
    DOI 10.1016/j.clinbiochem.2022.05.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Conference proceedings: The beauty of real-world data. EHL factor concentrates contribute to declining annual bleed rates

    Wüst, F / Pekrul, I / Ganslmeier, M / Spannagl, M / Möhnle, P

    Hämostaseologie

    2023  Volume 43, Issue S 01

    Event/congress GTH Congress 2023 - 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research - The patient as a benchmark, Frankfurt, Germany, 2023-02-21
    Language English
    Publishing date 2023-02-01
    Publisher Georg Thieme Verlag
    Publishing place Stuttgart ; New York
    Document type Article ; Conference proceedings
    ZDB-ID 801512-0
    ISSN 2567-5761 ; 0720-9355
    ISSN (online) 2567-5761
    ISSN 0720-9355
    DOI 10.1055/s-0042-1760554
    Database Thieme publisher's database

    More links

    Kategorien

  6. Article ; Online: Antikoagulation in der Intensivmedizin.

    Möhnle, Patrick / Bruegel, Mathias / Spannagl, Michael

    Medizinische Klinik, Intensivmedizin und Notfallmedizin

    2021  Volume 116, Issue 6, Page(s) 499–507

    Abstract: Critically ill patients are at high risk of hemostasis disorders, which can be associated with both an increased risk of bleeding and an increased risk of thromboembolic events. In the case of acute vascular events, specific therapy with drug ... ...

    Title translation Anticoagulation in intensive care medicine.
    Abstract Critically ill patients are at high risk of hemostasis disorders, which can be associated with both an increased risk of bleeding and an increased risk of thromboembolic events. In the case of acute vascular events, specific therapy with drug anticoagulation or platelet aggregation inhibition is essential. In patients with pre-existing conditions, the appropriate continuation of anticoagulation during intensive care treatment is important. Furthermore, in everyday clinical practice, prophylaxis of thromboembolism as well as the question of potential therapeutic options in the treatment of sepsis and infection-triggered disorders of blood coagulation are important. Specific questions arise with the use of extracorporeal devices such as renal replacement and circulatory assist systems. A number of new anticoagulation and anti-platelet drugs have become available in recent years. Laboratory monitoring of anticoagulation is central. In this overview, current aspects of these topics are presented.
    MeSH term(s) Anticoagulants/adverse effects ; Blood Coagulation ; Blood Coagulation Disorders ; Critical Care ; Hemorrhage/chemically induced ; Humans
    Chemical Substances Anticoagulants
    Language German
    Publishing date 2021-08-25
    Publishing country Germany
    Document type Journal Article ; Review
    ZDB-ID 2636018-4
    ISSN 2193-6226 ; 1435-1420 ; 0723-5003 ; 2193-6218 ; 0175-3851
    ISSN (online) 2193-6226 ; 1435-1420
    ISSN 0723-5003 ; 2193-6218 ; 0175-3851
    DOI 10.1007/s00063-021-00849-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Book ; Thesis: In-vitro- und In-vivo-Charakterisierung eines gereinigten AT-III-Heparin-Komplexes

    Spannagl, Michael

    1991  

    Author's details vorgelegt von Michael Spannagl
    Size [2], 48 S. : graph. Darst.
    Document type Book ; Thesis
    Thesis / German Habilitation thesis München, Univ., Diss., 1991
    HBZ-ID HT003948129
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  8. Article: Direkte Orale Antikoagulanzien-Labormonitoring

    Spannagl, M.

    Die medizinische Welt

    2015  Volume 66, Issue 2, Page(s) 66

    Language German
    Document type Article
    ZDB-ID 202650-8
    ISSN 0025-8512
    Database Current Contents Medicine

    More links

    Kategorien

  9. Article ; Online: Insufficient Data.

    Schachtner, Thomas / Spannagl, Michael

    Deutsches Arzteblatt international

    2018  Volume 115, Issue 13, Page(s) 220

    MeSH term(s) Arthroplasty, Replacement ; Surveys and Questionnaires ; Tranexamic Acid
    Chemical Substances Tranexamic Acid (6T84R30KC1)
    Language English
    Publishing date 2018-04-19
    Publishing country Germany
    Document type Letter ; Comment
    ZDB-ID 2406159-1
    ISSN 1866-0452 ; 1866-0452
    ISSN (online) 1866-0452
    ISSN 1866-0452
    DOI 10.3238/arztebl.2018.0220a
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Book ; Online ; Thesis: The genomic repertoire of complex and polyploid cereal genomes

    Spannagl, Manuel

    2015  

    Author's details Manuel Spannagl
    Language English
    Size Online-Ressource
    Document type Book ; Online ; Thesis
    Thesis / German Habilitation thesis Techn. Univ., Diss.--München, 2015
    Database Former special subject collection: coastal and deep sea fishing

    More links

    Kategorien

To top